To further validate our findings in GBM cells, we used CRISPR/Cas9 genome-editing technology to knockout endogenous DHHC9 and reconstitutively expressed Flag-tagged WT rDHHC9 or rDHHC9 C169S mutant (Fig. 3c). Here, ZDHHC9 is linked to glioblastoma.